...
首页> 外文期刊>British Journal of Pharmacology >Histamine H_1 receptor occupancy in human brains after single oral doses of histamine H_1 antagonists measured by positron emission tomography
【24h】

Histamine H_1 receptor occupancy in human brains after single oral doses of histamine H_1 antagonists measured by positron emission tomography

机译:正电子发射断层扫描法测定单次口服组胺H_1拮抗剂后人脑中组胺H_1受体的占有率

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

1. Histamine H_1 receptor occupancy in the human brain was measured in 20 healthy young men by positron emission tomography (PET) using [~(11)C]-doxepin. 2. (+)-Chlorpheniramine, a selective and classical antihistamine, occupied 76.8 ± 4.2% of the averaged values of available histamine H_1 receptors in the frontal cortex after its administration in a single oral dose of 2 mg. Intravenous administration of 5 mg (+)-chlorpheniramine almost completely abolished the binding of [~(11)C]-doxepin to H_1 receptors (H_1 receptor occupancy: 98.2 ± 1.2%). 3. Terfenadine, a nonsedative antihistamine, occupied 17.2 ± 14.2% of the available H_1 receptors in the human frontal cortex after its administration in a single oral dose of 60 mg. 4. There was no correlation between H_1 receptor occupancy by terfenadine and the plasma concentration of the active acid metabolite of terfenadine in each subject. 5. PET data on human brain were essentially compatible with those on H_1 receptor occupancy in guinea-pig brain determined by in vivo binding techniques, although for the same H_1 receptor occupancy the dose was less in human subjects than in guinea-pigs. 6. The PET studies demonstrated the usefulness of measuring H_1 receptor occupancy with classical and second-generation antihistamines in human brain to estimate their unwanted side effects such as sedation and drowsiness quantitatively.
机译:1.使用[〜(11)C] -doxepin,通过正电子发射断层扫描(PET)对20名健康的年轻男性中的组胺H_1受体占有率进行了测量。 2.(+)-氯苯那敏是一种选择性的经典抗组胺药,单次口服2 mg后,其额叶皮层中可用的组胺H_1受体平均值占其平均值的76.8±4.2%。静脉内注射5 mg(+)-氯苯那敏几乎完全消除了[〜(11)C]-多塞平与H_1受体的结合(H_1受体占有率:98.2±1.2%)。 3.特非那定是一种非镇静性抗组胺药,单次口服60 mg后,其在人类额叶皮层中占有可用H_1受体的17.2±14.2%。 4.在每个受试者中,特非那定的H_1受体占有率与特非那定的活性酸代谢产物的血浆浓度之间没有相关性。 5.关于人脑的PET数据与通过体内结合技术确定的豚鼠脑中H_1受体占有率的数据基本相容,尽管对于相同的H_1受体占有率,人受试者的剂量要比豚鼠少。 6. PET研究表明,在人脑中测量经典和第二代抗组胺药对H_1受体的占有率以评估其不良副作用(如镇静和嗜睡)是有用的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号